| Journal Name | Nature Reviews Cancer |
| Abbreviation | Nat Rev Cancer |
| Journal Start Year | 2001 |
| Print ISSN | 1474-175X |
| Online ISSN | 1474-1768 |
| Subject | Biochemistry |
| Sub Subject | Medicine |
| Country | United Kingdom (GB) |
| Publisher | Nature Publishing Group |
| Rss Feed | |
| Subscribe | Subscribe Journals |
Nature Reviews Cancer aims to be the premier source of reviews and commentaries for the scientific communities we serve. We strive to publish articles that are authoritative, accessible and enhanced with clearly understandable figures, tables and other display items. We want to provide unparalleled service to authors, referees and readers, and we work hard to maximize the usefulness and impact of each article. The journal publishes Research Highlights, Comments, Reviews and Perspectives relevant to cancer researchers, with our broad scope ensuring that the articles we publish reach the widest possible audience.
Aims & Scope
The ultimate aim of cancer research is to eliminate this common and devastating disease from the human population. To develop more effective prevention methods we need to understand what triggers tumorigenesis. To diagnose precancerous lesions and early-stage cancers quickly and accurately we need to detect the earliest molecular changes leading to each type of cancer. To determine a patient's prognosis we need to appreciate which molecular changes affect tumour growth rate and metastasis. And to tailor therapies to individual tumours we need to understand the fundamental differences, not only between a cancer cell and a 'normal' cell, but also between one cancer cell and another. All of these goals depend on a combination of basic and applied research. Nature Reviews Cancer aims to be a gateway from which cancer researchers — from those investigating the molecular basis of cancer to those involved in translational research — access the information that they need to further the ability to diagnose, treat and ultimately prevent cancer.
Aims & Scope
The ultimate aim of cancer research is to eliminate this common and devastating disease from the human population. To develop more effective prevention methods we need to understand what triggers tumorigenesis. To diagnose precancerous lesions and early-stage cancers quickly and accurately we need to detect the earliest molecular changes leading to each type of cancer. To determine a patient's prognosis we need to appreciate which molecular changes affect tumour growth rate and metastasis. And to tailor therapies to individual tumours we need to understand the fundamental differences, not only between a cancer cell and a 'normal' cell, but also between one cancer cell and another. All of these goals depend on a combination of basic and applied research. Nature Reviews Cancer aims to be a gateway from which cancer researchers — from those investigating the molecular basis of cancer to those involved in translational research — access the information that they need to further the ability to diagnose, treat and ultimately prevent cancer.
Subjects Covered:
Nature Reviews Cancer is a Biochemistry and Medicine Journal and published by Nature Publishing Group. See also a list of Biochemistry and Medicine Journals.
An abbreviation is a shortened form of a word or phrase, by any method. It may consist of a group of letters or words taken from the full version of the word or phrase.
The ISO4 Abbreviation of Nature Reviews Cancer is Nat Rev Cancer.
Nature Publishing Group is the publisher of the Nature Reviews Cancer. Visit for all Nature Publishing Group journals, click here : Nature Publishing Group List of Journals.
An International Standard Serial Number is an eight-digit serial number used to uniquely identify a serial publication, such as a magazine. The ISSN is especially helpful in distinguishing between serials with the same title
"Nature Reviews Cancer" Journal Print ISSN : 1474-175X, and Online ISSN (eISSN) : 1474-1768
| Nature Reviews Cancer Print ISSN : | 1474-175X |
| Nature Reviews Cancer eISSN : | 1474-1768 |
The University Grants Commission of India (UGC India) is the primary regulatory body created by the Indian Government in accordance with the UGC Act of 1956 under the Ministry of Human Resource Development.
It has been made responsible for the coordination of Indian Universities, determination of the standards for Indian universities and maintenance of standards of higher education in India.
Yes Nature Reviews Cancer is Indexed By UGC Care. UGC Approved Journals.
PubMed is a free search engine accessing primarily the MEDLINE database of references and abstracts on life sciences and biomedical topics. The United States National Library of Medicine at the National Institutes of Health maintain the database as part of the Entrez system of information retrieval.
Yes the Nature Reviews Cancer is PUBMED Indexed Journal.
| Nature Reviews Cancer PUBMED Indexed Journal : |
|
Peer review means that a board of scholarly reviewers in the domain of the journal, review materials they publish for quality of research and adherence to editorial standards of the journal, before articles are accepted for publication.
It’s the ultimate litmus test for scientists and researchers to verify their findings.
When an article on an experiment and its hypothesis is submitted to a scholarly journal for publishing then it is meticulously tested.
If a journal makes an article goes through the process of ‘peer-review’ before being published then it is a peer-review journal.
Yes Nature Reviews Cancer is Peer-Reviewed Journal and Published by Nature Publishing Group.
The Nature Reviews Cancer Journal is Indexed with Pubmed, Scopus, UGC (University Grants Commission).
| Nature Reviews Canceris PUBMED Indexed Journal : |
|
| Nature Reviews Cancer is Web of Science Indexed Journal : |
|
| Nature Reviews Cancer is UGC Approved Journal : |
|
The Impact Factor is also known by the name of Journal Impact Factor of an Academic Journal.
It is based on the scientometric index that shows the annual average number of citations. Moreover, impact factor is having all the information which is published in the last two years in the given journal received.
The Impact Factor of Nature Reviews Cancer is 60.716 (2024) Impact factor .
| Nature Reviews Cancer Impact Factor : | 60.716 (2024) |
| Note : This information is taken from the Journal Citation Reports™ (Clarivate). | |
Visit for all Journals Impact factor List
